Evidence map›Paper›PMID 37577933›Full record

Observational studyJournal of the American Heart Association2023

Changes in Doppler-Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure.

Faeq Husain-Syed, Narayana Sarma V Singam, Jason K Viehman, Lisa Vaughan, Pascal Bauer, Henning Gall, Khodr Tello, Manuel J Richter, Athiththan Yogeswaran, Gregorio Romero-González and 7 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03039959 (Predictive Value of Renal Venous Flow Profiles for Adverse Outcomes in Right Heart Failure), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03039959 completednot on this map

Predictive Value of Renal Venous Flow Profiles for Adverse Outcomes in Right Heart Failure

Typeobservational_patient_registrySponsorUniversity of GiessenRan2016 to 2019Enrolled421ConditionsPulmonary Hypertension, Cardiorenal Syndrome, Heart FailureArmsNo intervention
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 4 countries.

Faeq Husain-SyedDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.ORCID 0000-0001-6742-5052
Narayana Sarma V SingamDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-6289-2273
Jason K ViehmanDivision of Clinical Trials and Biostatistics Mayo Clinic Rochester MN.
Lisa VaughanDivision of Clinical Trials and Biostatistics Mayo Clinic Rochester MN.ORCID 0000-0002-5159-7738
Pascal BauerDivision of Cardiology and Angiology, Department of Internal Medicine I University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.
Henning GallDepartment of Internal Medicine Universities of Giessen and Marburg Lung Center, Institute for Lung Health, Cardio-Pulmonary Institute, Member of the German Center for Lung Research Giessen Germany.ORCID 0000-0001-7016-7373
Khodr TelloDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.ORCID 0000-0002-5557-623X
Manuel J RichterDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.
Athiththan YogeswaranDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.ORCID 0000-0001-9505-8608
Gregorio Romero-GonzálezDepartment of Nephrology University Hospital Germans Trias i Pujol Barcelona Spain.ORCID 0000-0001-7481-3678
Mitchell H RosnerDivision of Nephrology University of Virginia School of Medicine Charlottesville VA.
Claudio RoncoInternational Renal Research Institute of Vicenza, Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital Vicenza Italy.
Birgit AssmusDivision of Cardiology and Angiology, Department of Internal Medicine I University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.
Hossein Ardeschir GhofraniDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.ORCID 0000-0002-2029-4419
Werner SeegerDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.ORCID 0000-0003-1946-0894
Horst-Walter BirkDepartment of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.
Kianoush B KashaniDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine Mayo Clinic Rochester MN.ORCID 0000-0003-2184-3683
Justus-Liebig-Universität Gießen · DEMayo Clinic · USGerman Center for Lung Research · DEHospital Universitari Germans Trias i Pujol · ESMedStar Washington Hospital Center · USUniversity of Padua · ITUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The impact of changes in Doppler-derived kidney venous flow in heart failure (HF) is not well studied. We aimed to investigate the association of Doppler-derived kidney venous stasis index (KVSI) and intrakidney venous-flow (IKVF) patterns with adverse cardiorenal outcomes in patients with HF. Methods and Results In this observational cohort study, consecutive inpatients with HF referred to a nephrologist because of a history of diuretic resistance and abnormal kidney function (n=216) underwent spectral kidney assessments after admission (Doppler 1) and 25 to 35 days later (Doppler 2) to identify IKVF patterns (continuous/pulsatile/biphasic/monophasic) and KVSI levels. Cox proportional hazard regression models were used to evaluate the associations between KVSI/IKVF patterns at Doppler 1 as well as changes from Doppler 1 to Doppler 2 and risk of cardiorenal events up to 18 months after admission. Worsening HF or death occurred in 126 patients. Both baseline KVSI (hazard ratio [HR], 1.49 [95% CI, 1.37-1.61] per 0.1-unit increase) and baseline IKVF pattern (HR, 2.47 [95% CI, 2.01-3.04] per 1 pattern severity increase) were significantly associated with worsening HF/death. Increases in both KVSI and IKVF pattern severity from Doppler 1 to 2 were also associated with an increased risk of worsening HF/death (HR, 3.00 [95% CI, 2.08-4.32] per 0.1-unit increase change; and HR, 6.73 [95% CI, 3.27-13.86] per 1 pattern increase in severity change, respectively). Similar results were observed for kidney outcomes. Conclusions Baseline kidney venous flow predicted adverse cardiorenal events, and inclusion of serial kidney venous flow in cardiorenal risk stratification could facilitate clinical decision-making for patients with HF. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03039959.

Indexed as

Heart FailureVascular DiseasesHumansKidneycardiorenal syndromescongestive nephropathyintrarenal venous‐flow patternsrenal venous stasis indexvenous congestion

Identifiers

PMID37577933
PMCPMC10492931
OpenAlexW4385795089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.